Verve Therapeutics Gets FDA Fast Track Designation for VERVE-102-April 2024-www.financetom.com

Verve Therapeutics Gets FDA Fast Track Designation for VERVE-102

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Verve Therapeutics Gets FDA Fast Track Designation for VERVE-102

Apr 11, 2025 4:57 AM

07:40 AM EDT, 04/11/2025 (MT Newswires) -- Verve Therapeutics ( VERV ) said Friday the US Food and Drug Administration granted fast track designation for its experimental VERVE-102 treatment for hyperlipidemia and high lifetime cardiovascular risk to lower low-density lipoprotein cholesterol.

The company is testing VERVE-102 in a phase 1b clinical trial. The study's demographic and initial safety and efficacy data are expected in Q2.

Verve Therapeutics ( VERV ) shares were up 4.9% in recent premarket activity.

Previous page： Boyd Gaming's Q1 Adjusted Earnings, Revenue Decline Next page： Casella Waste Systems Swings to Q1 Adjusted Loss, Revenue Rises; 2024 Outlook Affirmed

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Boyd Gaming's Q1 Adjusted Earnings, Revenue Decline

Apr 26, 2024

05:43 AM EDT, 04/26/2024 (MT Newswires) -- Boyd Gaming ( BYD ) reported Q1 adjusted earnings Thursday of $1.51 per diluted share, down from $1.71 a year earlier. Analysts polled by Capital IQ expected $1.57. Revenue for the quarter ended March 31 was $960.5 million, compared with $964 million a year earlier. Analysts polled by Capital IQ expected $954.4 million....

Casella Waste Systems Swings to Q1 Adjusted Loss, Revenue Rises; 2024 Outlook Affirmed

Apr 26, 2024

05:46 AM EDT, 04/26/2024 (MT Newswires) -- Casella Waste Systems ( CWST ) reported a Q1 adjusted loss late Thursday of $0.01 per diluted share, swinging from earnings of $0.10 a year earlier. Analysts polled by Capital IQ expected a loss of $0.02. Revenue for the quarter ended March 31 was $341 million, up from $262.6 million a year earlier....

U.S. Energy-Related Carbon Dioxide Emissions Decline 3% in 2023, EIA Reports

Apr 26, 2024

05:51 AM EDT, 04/26/2024 (MT Newswires) -- U.S. energy-related carbon dioxide (CO2) emissions fell 3%, or 134 million metric tons, in 2023 with most of the decrease occurring in the electric power sector, the U.S. Energy Information Administration reported on Thursday. Total U.S. energy-related CO2 emissions amounted to 4.81 billion metric tons last year, the lowest level since 2020, the...

Deals of the day-Mergers and acquisitions

Apr 26, 2024

April 26 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Friday: ** Buyout firm L Catterton has agreed to buy a majority stake in family-owned KIKO Milano in a deal which a source close to the matter said valued the Italian accessible make-up maker at around 1.4 billion euros ($1.5 billion) including debt....